Skip to main content
Clinical Trials/NCT04202588
NCT04202588
Unknown
Not Applicable

Gastrointestinal Symptoms Characteristics and Chinese Medicine Patterns in Patients With Functional Gastrointestinal Disorders (FGIDs) in China: a Multicenter Cross-sectional Investigation

Hong Kong Baptist University1 site in 1 country4,632 target enrollmentJanuary 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Functional Gastrointestinal Disorders
Sponsor
Hong Kong Baptist University
Enrollment
4632
Locations
1
Primary Endpoint
Distribution of different subtypes with Functional gastrointestinal disorders (FGIDs) in China
Last Updated
4 years ago

Overview

Brief Summary

The investigators will conduct a multicenter cross-sectional study to discover symptom characteristics, quality of life, severity of anxiety and depression, status of lactose intolerance and treatment satisfaction of current Chinese Medicine (CM) regimens of outpatients with FGIDs. In the meanwhile, the investigators will also analyze the characters of CM patterns and corresponding elements, then explore the potential relationship between CM patterns and FGIDs' subtypes.

Detailed Description

This is a multicenter cross-sectional study to discover symptom characteristics, quality of life, severity of anxiety and depression, status of lactose intolerance and treatment satisfaction of current Chinese Medicine (CM) regimens of outpatients with FGIDs. Afterwards, the investigators will explore the potential relationship between CM patterns and FGIDs' subtypes based on collected information. It is estimated that 4,632 outpatients from 18 centers across China will be recruited. Various demographic and disease-related information will be documented, including name, gender, age, education level, marital status, job category, disease course, medical consultation experience, current CM regimens and rationale, and treatment satisfaction. Patients will also complete a series of scales, containing, Rome IV Diagnostic Questionnaire, Patient-Reported Outcome (PRO) scale, the 36-Item Short Form Survey (SF-36), Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), lactose food frequency questionnaire (Lactose FFQ) and CM pattern scale. The primary outcome will be the symptom characteristics of outpatients with FGIDs. Secondary outcomes include population characteristics of FGID patients (quality of life, emotional status, lactose intolerance status, and satisfaction level of CM interventions), and potential association between CM patterns and FGIDs' subtypes.

Registry
clinicaltrials.gov
Start Date
January 1, 2020
End Date
January 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Zhong Lidan

Assistant Professor

Hong Kong Baptist University

Eligibility Criteria

Inclusion Criteria

  • Symptoms onset at least 3 months
  • Meet the diagnostic criteria of FGIDs
  • Informed consent and ability to read and understand questionnaires

Exclusion Criteria

  • Combined with organic gastrointestinal diseases
  • Appearance of gastrointestinal alarm symptoms
  • Combined with mental disorders

Outcomes

Primary Outcomes

Distribution of different subtypes with Functional gastrointestinal disorders (FGIDs) in China

Time Frame: 2 years

The percentage of the different subtypes with FGIDs by Rome IV Diagnostic Criteria

The health-related quality of life (HRQOL) of outpatients with FGIDs in China

Time Frame: 2 years

The HRQOL scale contains 36 questions scoring from 0 to 4. Higher score means a worse outcome. The highest total score is 144.

Secondary Outcomes

  • Treatment satisfaction score of CM interventions in outpatients with FGIDs in China(2 years)
  • HAMD scoring of outpatients with FGIDs in China(2 years)
  • HAMA scoring of outpatients with FGIDs in China(2 years)
  • Demographic characteristics of outpatients with FGIDs in China(2 years)
  • Quality of life of outpatients with FGIDs in China(2 years)

Study Sites (1)

Loading locations...

Similar Trials